Thursday, 16 September 2021

3D Printing: The Future of Construction

 



The increasing use of 3D printing in the construction industry is driving the market growth. 3D printing is being widely used for constructing complex building structures using modeling software programs. The implementation of 3D printing technology offers high accuracy, improved efficiency, reduced labor cost, and greater speed of construction. The growing adoption of 3D printers for prototyping and designing in the construction sector, coupled with accuracy achieved in the end product and reduced manufacturing expenditure, is driving the market growth.



Flow Diverters Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 Flow Diverters Market Growth & Trends

The global flow diverters market size is anticipated to reach USD 874.10 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. Increasing research activities pertaining to the treatment of brain aneurysm and the rising prevalence of cerebral aneurysm are driving the market.

An increasing number of patients suffering from hypertension significantly increases the risk of a brain aneurysm. This is expected to drive market growth in the coming years. Hypertension or trauma to blood vessels is the major cause of brain aneurysm. As per the WHO facts 2019, around 1.1 billion people worldwide are suffering from hypertension.

In addition, several initiatives launched by the government of various countries to improve public awareness and treatment related to cerebral aneurysm are driving the market. For instance, the Brain Aneurysm Foundation of Canada works toward educating and spreading awareness about brain aneurysms. This program includes early access to monthly educational webinars and social media campaigns for highlighting the prevalence of brain aneurysms.

Moreover, companies are developing and launching technologically advanced products for attracting more customers in the market. For instance, in January 2020, MicroVention, Inc., (part of Terumo Corporation) received the U.S. FDA Premarket Approval for its FRED to treat intracranial aneurysms. It utilizes self-expanding, woven nitinol mesh to re-direct blood flow and promote aneurysm occlusion.

Request a free sample copy or view report summary: Flow Diverters Market Report

Flow Diverters Market Report Highlights

  • On the basis of diameter size, the >5 mm flow diverters segment dominated the overall market with a share of 65.8% in 2019 owing to their increasing demand and application in treating giant and wide intracranial aneurysms (>10 mm vessel diameter)
  • North America dominated the market with the highest revenue share of 46.5% in 2019 owing to the high prevalence rate of brain aneurysms and the presence of key market players in this region
  • In Asia Pacific, the market is expected to witness the highest CAGR of 14.4% from 2020 to 2027 owing to the presence of a huge target population and increasing healthcare spending in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-flow-diverters-market

Flow Diverters Market Segmentation

Grand View Research has segmented the global flow diverters market on the basis of diameter size and region:

Flow Diverters Diameter Size Outlook (Revenue, USD Million, 2016 - 2028)

  • 2-3 mm Flow Diverters
  • 3-4 mm Flow Diverters
  • 4-5 mm Flow Diverters
  • >5 mm Flow Diverters

Flow Diverters Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Flow Diverters Market

  • Medtronic
  • Stryker Corporation
  • MicroVention, Inc. (Terumo Corporation)
  • BALT Extrusion SA
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • Phenox GmbH
  • Acandis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Large Molecule Bioanalytical Testing Services Market Size is Expected To Reach USD 3.0 Billion by 2028

 Large Molecule Bioanalytical Testing Services Market Growth & Trends

The global large molecule bioanalytical testing services market size is expected to reach USD 3.0 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 9.5% from 2021 to 2028. The major factor attributing to market growth is the increased application of bioanalytical testing in clinical trials of biomarkers, large molecules, and others.

Rising prevalence of HIV, infectious disease, and others has led to increasing demand for bioanalytical testing services globally. Moreover, increasing government initiatives to control the outbreak of various infectious diseases such as Corona and Ebola virus is anticipated to offer more opportunities for the market. Hence, the market is expected to grow over the assessment period.

The market is expected to witness lucrative growth during the forecast period due to increased research activities and the presence of a huge pipeline of peptides, biologics, and amino acids based molecules. Additionally, bioanalysis of large molecules requires skilled professionals with innovative analytical instruments and infrastructure. These services are readily offered by bioanalytical testing service providers and are likely to propel the growth of the market during the assessment period.

North America accounted for the highest share in 2019. The U.S. holds the highest market share due to the increasing prevalence of various chronic diseases and the growing adoption of large molecule therapeutics as an alternative for small molecules.

For example, according to International Diabetes Federation Report 2019, around 49.0 million geriatric population in the U.S. has diabetes and this has led to increasing requests for bioanalysis of the novel (large molecule compounds) peptide therapeutics such as glucagon-like peptide 1(GLP-1). Due to this reason, the market is expected to show growth over the forecast period. In addition, the presence of major players in the region contributed to market growth.

Request a free sample copy or view report summary: Large Molecule Bioanalytical Testing Service Market Report

Large Molecule Bioanalytical Testing Services Market Report Highlights

  • By type, the clinical segment held the largest market share in 2019 owing to increasing demand for clinical trials due to the rising prevalence of various infectious diseases
  • Bioavailability held the largest market share of 20.9% in 2019 owing to increasing adoption in generic drug manufacturing
  • The oncology segment held the largest revenue share due to the increasing prevalence of cancer globally
  • The U.S. is expected to witness the fastest growth over the forecast period owing to the growing adoption of advanced therapeutic techniques in the country.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-large-molecule-bioanalytical-testing-service-market

Large Molecule Bioanalytical Testing Services Market Segmentation

Grand View Research has segmented the global large molecule bioanalytical testing services market based on phase, type, test type, therapeutic area, end-user, and region:

Large Molecule Bioanalytical Testing Services Phase Outlook (Revenue, USD Million, 2016 - 2028)

  • Preclinical
    • With Antibody
    • Without Antibody (ELISA Based Assay)
  • Clinical

Large Molecule Bioanalytical Testing Services Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Pharmacokinetics
  • ADA
  • Others

Large Molecule Bioanalytical Testing Services Test Type Outlook (Revenue, USD Million, 2016 - 2028)

  • ADME
  • PK
  • PD
  • Bioavailability
  • Bioequivalence
  • Other Tests

Large Molecule Bioanalytical Testing Services Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Neurology
  • Others

Large Molecule Bioanalytical Testing Services End-user Outlook (Revenue, USD Million, 2016 - 2028)

  • SMEs
    • CROs & CMOs
    • Sponsor Organizations
    • Others (Academic Institutes, etc.)
  • Large Firms
    • CROs & CMOs
    • Sponsor Organizations
    • Others (Academic Institutes, etc.)

Large Molecule Bioanalytical Testing Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • India
    • Japan
    • China
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Large Molecule Bioanalytical Testing Services Market

  • Covance, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA
  • Toxikon
  • Intertek Group plc
  • Pace Analytical Services LLC
  • PPD, INC.
  • ICON plc
  • Charles River Laboratories International

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Scar Treatment Market Revenue is Expected to Reach USD 46.3 Billion by 2028: Grand View Research Inc.

 Scar Treatment Market Growth & Trends 

The global scar treatment market size is expected to reach a value of USD 46.3 billion by 2028 registering a CAGR of 10.1%, according to a new report by Grand View Research, Inc. Scar treatment market is developing at a fast rate due to the growing awareness among people regarding aesthetics. Acne scars are one of the most common concerns. Rise in the number of road accidents also results in several marks, which many a time require surgical assistance.

Hence, patients who have undergone such surgeries are generally provided with topical products for scar reduction. Cosmetic surgeries with laser instruments are also being undertaken for treating severe marks from road accidents. To remove such marks, plastic surgeries or resurfacing laser therapies are being preferred. Technologically advanced scar removal products minimize pain and facilitate a hassle-free healing process. For instance, UltraPulse by Lumenis uses CO2 laser for the treatment of acne scars reduces the risk of pain during the treatment process.

Request a free sample copy or view report summary: Scar Treatment Market Report

Scar Treatment Market Report Highlights

  • Topical products led the global scar removal treatment market in 2018 due to higher demand for creams and gels for treating scars, such as acne, surgical marks, and burns
  • Laser products are anticipated to witness the fastest CAGR over the forecast period due to the introduction of technically advanced laser instruments
  • North America was the dominant regional market in 2018 owing to the high penetration of laser-based products in skin rejuvenation and scar treatment

Access Press Release@ https://www.grandviewresearch.com/press-release/global-scar-treatment-market

Scar Treatment Market Segmentation

Grand View Research has segmented the global scar treatment market on the basis of product, scar type, end use, and region:

Scar Treatment Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Topical Products
    • Creams
    • Gels
    • Silicon Sheets
    • Others
  • Laser Products
    • CO2 Laser
    • Pulse-dyed Laser
    • Others
  • Injectables
  • Others

Scar Treatment Scar Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Atrophic Scars
  • Hypertrophic and Keloid Scars
  • Contracture Scars
  • Stretch Marks

Scar Treatment End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Clinics
  • Retail Pharmacies/ E-commerce

Scar Treatment Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Singapore
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of the Scar Treatment Market

  • Smith & Nephew PLC
  • Lumenis
  • Merz Pharmaceuticals, LLC
  • Sonoma Pharmaceuticals, Inc.
  • Cynosure
  • CCA Industries, Inc.
  • Newmedical Technology Inc.
  • Mölnlycke Health Care AB
  • Suneva Medical

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Parenteral Nutrition Market Analysis ,Industry Growth And Future Scope: Grand View Research Inc.

 Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 9.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.9% from 2021 to 2028. The growing burden of chronic diseases, such as diabetes, cancer, and other neurological conditions, increasing deficiency of essential nutrients among critically ill patients, and the growing awareness regarding hospital-related malnutrition are some of the major factors driving the adoption of parenteral nutrition. Parenteral nutrition (PN) plays a vital role in supporting better health outcomes as malnutrition can have a serious impact on hospitalized patients. Hospitalized adults diagnosed with malnutrition have a longer length of hospital stay and higher recovery costs and are five times more likely to die compared to other adult inpatients.

The consumption of fat emulsions as part of PN has significantly increased among preterm neonates in their initial life after birth owing to their intolerance to full enteral nutrition and benefits of parenteral nutrition that provides a relatively safe means for preventing nutritional deficiency. A research article published in Eastern Mediterranean Health Journal in 2017 reported that the prevalence of malnutrition among hospitalized infants and children in various countries ranged between 6.1% and 40.9%. Intravenous lipid emulsions (ILEs) are an essential component of PN, majorly in preterm and very-low-birth infants as these formulations have revolutionized the management of infants suffering from gastrointestinal (GI) anomalies and other conditions, including intestinal failure, by providing nutritional support for intestinal growth.

An increase in accidents, a higher incidence of preterm deliveries, a high natality rate, and the presence of critically ill patients with impaired enteral route physiological functioning is expected to drive the adoption of parenteral nutrition as an alternative route of administration. Malnutrition and immune imparity numbers are the highest in Asia Pacific countries, summing up almost 62% of the world’s malnourished cases. High infection rates, the lack of awareness, and poor quality of water supply and sanitation facilities are leading to a high prevalence of malnourishment in the Asia Pacific, creating a significant demand for parenteral nutrition sources to help fulfill nutritional requirements, thereby aiding the market growth.

Request a free sample copy or view report summary: Parenteral Nutrition Market Report

Parenteral Nutrition Market Report Highlights

  • The market growth can be attributed to owing to the increasing adoption of PN products for fulfilling adequate nutritional requirements
  • By nutrient type, the single dose amino acid solution segment dominated the market in 2020 owing to an increase in the influx of regulatory approved solutions
  • North America dominated the market in 2020 owing to the rising prevalence of chronic diseases and malnutrition, an increasing number of new launches, and U.S. FDA approvals in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-parenteral-nutrition-market

Parenteral Nutrition Market Segmentation

Grand View Research, has segmented the global parenteral nutrition market on the basis of nutrient type and region:

Parenteral Nutrition Nutrient Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins & Minerals

Parenteral Nutrition Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • Spain
    • Italy
    • France
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Parenteral Nutrition Market

  • Baxter
  • Grifols, S.A.
  • Allergan
  • Otsuka Pharmaceutical Factory, Inc.
  • Actavis Inc.
  • Braun Melsungen AG
  • Fresenius Kabi AG
  • ViforPharma
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Pfizer Inc. (Hospira Inc.)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Veterinary Orthopedics Market Expected To Propel Industry Growth By 2028: Grand View Research Inc.

 Veterinary Orthopedics Market Growth & Trends

The global veterinary orthopedics market size is anticipated to reach USD 930.1 million by 2028, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.3% from 2021 to 2028. The growing pet population, the prevalence of pet obesity and arthritis, which may require orthopedic surgery, are expected to drive the market. Moreover, increasing technological advancements in veterinary devices is another driver expected to contribute to the market growth.

According to the American Pet Products Association (APPA), about 84.9 million American homes (67% of U.S. households) owned a pet in 2019. This number is significantly greater than 2017 statistics wherein nearly 60.2 million U.S. households had at least one pet dog.

In 2019, Americans spent USD 95.7 billion on pets, which was USD 5.2 billion more than the expenditure in 2018. The rise in the number of pet owners and, subsequently, expenditure on pets, is boosting the animal health industry, including veterinary orthopedics. Owners are concerned about their pets and, hence, the demand for efficient treatment is rising. This trend is expected to continue, thus, fueling market growth during the forecast period.

According to Association for Pet Obesity Prevention (APOP), 56% of dogs and 60% of cats were overweight or obese in the U.S., in 2018. Obesity increases pressure on joints and bones. According to APPA, nearly 20.8 million dogs in the U.S. had undergone orthopedic surgeries in 2016. The most common orthopedic surgeries carried out on canines were femoral head osteotomy, bones fracture repair, cruciate ligament repair, and medial patellar luxation.

The prevalence of osteoarthritis in animals is increasing because of obesity, which is boosting demand for veterinary orthopedic devices and surgeries. According to Kingsbrook Animal Hospital, 20% of all dogs-regardless of age-in the U.S. had osteoarthritis in 2017.

The COVID-19 pandemic significantly impacted the market, as the number of elective surgeries went down due to lockdown and quarantine measures. However, the market is anticipated to be driven by the resumption of elective surgeries. In March 2020, the Harmony Veterinary Center in compliance with government guidelines, suspended all its elective procedures, surgeries, and dentistry services during the COVID-19 outbreak. However, this does not change the underlying need for these procedures and the market is expected to grow significantly as surgeries return to pre-COVID numbers.

Request a free sample copy or view report summary: Veterinary Orthopedics Market Report

Veterinary Orthopedics Market Report Highlights

  • The growing pet population and ailments, combined with rising concern for zoonoses and pet expenditure, is anticipated to fuel market growth
  • The implants segment accounted for the largest revenue share of the product segment in 2020. This can be attributed to an increase in the number of cases of severe musculoskeletal injuries or orthopedic disorders, such as cruciate ligament tears or hip and elbow dysplasia. This increases the need for surgery and, thus, the demand for implants
  • The TTA segment held the largest revenue share in the application segment in 2020. Various factors driving the demand for this surgical method include increased ability to bear weight postsurgery, less pain, faster recovery, and fewer associated complications
  • The veterinary hospitals and clinics segment dominated the end-use segment in 2020, as a wide range of procedures and treatment options are available in these healthcare settings
  • In 2020, North America held a dominant revenue share in the market. This can be attributed to the local presence of key market players undertaking extensive strategic initiatives

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-orthopedics-market

Veterinary Orthopedics Market Segmentation

Grand View Research has segmented the global veterinary orthopedics market on the basis of product, application, end-use, and region:

Veterinary Orthopedics Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Instrument
  • Implants
    • Plates
      • Compression plates
      • Arthrodesis plates
      • Acetabulum plates
    • Screws
    • Others

Veterinary Orthopedics Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Total Knee Replacement
  • Total Hip Replacement
  • Total Elbow Replacement
  • Trauma Fixation
  • TPLO
  • TTA
  • Lateral Fixation
  • Others

Veterinary Orthopedics End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals & Clinics
  • Others

Veterinary Orthopedics Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

List of Key Players of Veterinary Orthopedics Market

  • Braun Melsungen AG
  • Veterinary Orthopedic Implants
  • Kyon AG
  • STERIS
  • Integra LifeSciences Corporation
  • Ortho Max Manufacturing Company Pvt. Ltd.
  • BioMedtrix, LLC
  • Surgical Holdings Veterinary
  • GerVetUSA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wednesday, 15 September 2021

Go Beyond Chatbots with an Intelligent Virtual Assistant

 



The need for improved efficiency across service-based companies and the integration of Artificial Intelligence (AI) powered virtual assistants among various devices such as tablets, computers, and smartphones, among others, is anticipated to boost the market growth. An Intelligent Virtual Assistant (IVA) is capable of fulfilling a wide range of customer service roles such as ease to navigate, offer product information, assist customers in paying bills, and carry out transfers or complete forms, and direct problem queries to human agents in customer service. Such factors are prompting banking and financial institution across the world to integrate virtual assistants, leading to industry growth.



The Next In-Vehicle Experience: Automotive Digital Cockpit

 



The Covid-19 pandemic has affected the overall automotive industry, leading to a subsequent decline in the growth of the market as a result of low automotive sales and new requirements. However, the increased adoption of in-vehicle telematics, infotainment system, safety and pollution sensors, navigation, and the internet of things is a prominent factor driving the demand for automotive digital cockpit solutions. Furthermore, the growing demand for improved comfort, safety, and convenience in vehicles, especially in emerging and developed economies, is anticipated to boost the growth of the market over the forecast period. The growing luxury and high-end car segment and rising use of autonomous vehicle technology are also likely to contribute to market growth.

Global L-carnitine Market Pegged For Strong Growth During 2021-2028: Grand View Research Inc.

 L-carnitine Market Growth & Trends

The global L-carnitine market size is expected to reach USD 276.0 million by 2028, expanding at a CAGR of 5.1%, as per a new report by Grand View Research Inc. Growing consumer awareness regarding product benefits, along with increasing demand from end-use industries such as pharmaceutical, nutraceutical, and animal feed, is projected to drive the market over the forecast period.

L-carnitine and its derivatives are used for numerous applications including male infertility, kidney treatment, cardiovascular diseases, weight reduction, and bone mass. It is also used in various products including animal feed, health supplements, functional drinks, medicines, and other nutraceutical products.

Manufacturers are focused on R&D activities to reduce the complexity in manufacturing techniques as well as product differentiation. Major manufacturers like Lonza, Ajinomoto, Sigma Tau Group, and Seikatsu have patented their manufacturing processes. Production of L-carnitine by chemical synthesis is executed on an industrial scale. However, manufacturers prefer bioprocess for the production, as the process generates higher yield and lesser waste as compared to chemical synthesis.

Companies engaged in the production and export of L-carnitine follow stringent standards such as current goods manufacturing procedure (CGMP), sanitary standard operation procedure (SSOP), and ISO standards. Companies offering food-grade products are required to obtain kosher and halal certifications.

In 2018, North America emerged as the largest regional market. The growth in this region can be attributed to increasing research and development activities in pharmaceutical and nutraceutical industries. Furthermore, increasing demand for pet supplements and animal feed formulations is expected to drive industry growth over the forecast period.

Request a free sample copy or view report summary: L-carnitine Market Report

L-carnitine Market Report Highlights

  • Increasing preventive healthcare in major economies across the globe, including U.S., China, and India, has led to rising consumption of functional drinks, which in turn, is expected to propel product demand
  • The market exhibits production of L-carnitine through biotechnological techniques using micro-organisms or enzymes. These processes use achiral precursors or racemic mixtures as raw materials for extraction of L-carnitine and offer the highest yield as compared to other means
  • Increasing demand for animal feed from emerging economies such as China, India, and Vietnam are expected to drive the feed grade product segment over the forecast period
  • Key L-Carnitine Market players include Lonza Group Ltd., Northeast Pharmaceutical Group Co., Ltd. (NEPG), Biosint S.p.A., Cayman Chemical, Merck KGaA, Tokyo Chemical Industry Co., Ltd., Ceva SantĂ© Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., Chengda Pharmaceuticals Co. Ltd., Huanggang Huayang Pharmaceutical Co. Ltd., and Hubei Yuancheng Technology Co. Ltd.
  • Manufacturers in the market enter into contracts with suppliers and buyers, thereby gaining a competitive edge in the market. They have also been investing heavily in R&D and capacity expansions to increase their market share.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-l-carnitine-market

L-carnitine Market Segmentation

Grand View Research has segmented the global L-Carnitine market on the basis of process, product, application, and region:

L-carnitine Process Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

  • Chemical Synthesis
  • Bioprocess

L-carnitine Product Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

  • Food & Pharma Grade
  • Feed Grade

L-carnitine Application Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

  • Animal Feed
  • Healthcare Products
  • Functional Food & Beverages
  • Medicines

L-carnitine Regional Outlook (Volume, Tons; Revenue, USD Thousand, 2017 - 2028)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK.
    • France
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Central & South America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia

List of Key Players of L-carnitine Market

  • Lonza
  • Northeast Pharmaceutical Group Co., Ltd. (NEPG)
  • Biosint S.p.A.
  • Cayman Chemical
  • Merck KGaA
  • Tokyo Chemical Industry Co., Ltd.
  • Ceva
  • Kaiyuan Hengtai Nutrition Co., Ltd.
  • ChengDa PharmaCeuticals Co., Ltd.
  • Huanggang Huayang Pharmaceutical Co. Ltd.
  • HuBeiYuancheng SaichuangTechnology Co, .Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surfing Apparel And Accessory Market Size Is Expected To Reach USD 1.82 Billion by 2028

 Surfing Apparel And Accessory Market Growth & Trends

The global surfing apparel and accessory market size is expected to reach USD 1.82 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.0% from 2021 to 2028. Surfing is gaining popularity among water adventurers as people could follow all the social distancing guidelines while surfing. Surfing clothes and accessories are also gaining popularity because surfing was one of the only sports that people could participate in during the pandemic.

In 2020, the surf apparel product segment held the largest market share, and this trend is likely to continue throughout the forecast period. The development of novel materials and technical textiles for the creation of fashionable and high-performance surfwear or apparel has aided market expansion. Furthermore, as the number of female surfers has increased, so does the demand for surfing-inspired clothing such as bikinis, swimsuits, shorts, t-shirts, short onesies, and vests made of water-resistant fabrics, such as polyester.

In the surf apparel industry, a recent trend has been the increase in the number of sustainable items. Consumers are choosing environmentally-friendly surf apparel that does not pollute the environment. The majority of surf clothing and accessory producers are based in Europe, Asia Pacific, and North America, where the necessary raw materials are readily available.

Since stand-alone shops were authorized to reopen in June, board-sports businesses have reported a surge in hard goods sales. On July 13, 2020, the state government issued a decree requiring stores in indoor malls in certain California counties to remain closed. According to Bob Abdel, co-owner and buyer of Huntington Beach, Calif.-based Jack's Surfboards, the business is good, the only issue is with the inventory. He stated that Surfboards, skateboards, and wetsuits are coveted commodities. Orders take five weeks to come to retailers and a lot of businesses were caught off guard. As a result, finding items has been quite difficult for consumers. Soft-goods sales have also been hampered by supply-chain problems. During the shutdown of non-essential industries, many surf apparel companies suspended manufacturing. There have also been issues with staffing industries and warehouses in the United States since some workers sought to avoid being exposed to COVID-19.

Channel Islands Surfboards, Quiksilver, Firewire Surfboards, and Billabong International Limited, among other prominent surf apparel manufacturers, have been concentrating on the production and design of innovative materials and technical fabrics for trendy and high-performance surfwear or apparel, which has positively impacted market growth.

Request a free sample copy or view report summary: Surfing Apparel And Accessory Market Report

Surfing Apparel And Accessory Market Report Highlights

  • The surf apparel product segment accounted for the largest share of over 75.0% in 2020. This is attributed to professional surfers' increased desire for accessories, such as wetsuit booties and reef socks
  • The online distribution channel segment is estimated to expand at the highest CAGR of 6.5% over the forecast period
  • North America held the largest share of over 45.0% in 2020 owing to the growing popularity of surfing among adventure enthusiasts in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surfing-apparel-accessories-market

Surfing Apparel And Accessory Market Segmentation

Grand View Research has segmented the global surfing apparel and accessory market on the basis of product, distribution channel, and region:

Surfing Apparel & Accessory Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Surf Apparel
  • Surf Accessories

Surfing Apparel & Accessory Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Offline
  • Online

Surfing Apparel & Accessory Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
  • Europe
    • UK.
    • France
    • Spain
  • Asia Pacific
    • Australia
    • New Zealand
  • Central & South America
    • Brazil
  • Middle East & Africa

List of Key Players of Surfing Apparel And Accessory Market

  • Billabong
  • Hurley, Inc.
  • O’Neill
  • RVCA
  • Volcom, LLC
  • GLOBE INTERNATIONAL LIMITED
  • REEF
  • Roxy, Inc.
  • Ltd.
  • Quiksilver, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biosimulation Market Size Is Anticipated To Reach USD 6.83 Billion by 2028

 Biosimulation Market Growth & Trends

The global biosimulation market size is anticipated to reach USD 6.83 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.9% from 2021 to 2028. The key factors fueling the market growth include the increasing incidence of chronic diseases, increase in healthcare digitization, and usage of biosimulation solutions in clinical trials and research.

The need for drug discovery and development amidst the prevalence of acute and chronic diseases has resulted in an increase in the allocation of funds for R&D activities, which has propelled the adoption of biosimulation solutions. In addition, a high drug attrition rate leads to an increase in the cost of clinical trials, which is expected to drive the clinical urgency to incorporate in silico biology approach. This approach significantly reduces the probability of drug failure by predicting biological interactions, thereby reducing the overall costs.

Arise in drug relapse rates, drug resistance cases, and limited availability of drugs to treat diseases such as AIDS have led to high clinical urgency for the adoption of biosimulation in applications, such as drug development and drug discovery.

The COVID-19 pandemic also had a significant impact on the market. Simulations Plus, for instance, launched the StrategiesPlus COVID-19 ACT Program in March 2020 for speeding consulting assistance to any organization involved in the COVID-19 research. As of November 2020, the company declared that its business was not materially adversely affected. However, the continuing spread of COVID-19 and the measures taken by the governments of the affected countries are likely to disrupt the supply chain and adversely impact its business and financial performance.

Surging demand for biosimulation software and services can also be attributed to their higher cost-efficiency. Biosimulation solutions enable cost-effective prediction of toxicity, adverse reactions, and efficacy of investigational drugs during early stages of product development, thus limiting the probability of drug relapse and adverse events at later stages.

Request a free sample copy or view report summary: Biosimulation Market Report

Biosimulation Market Report Highlights

  • In terms of product, software dominated the market in 2020. This can be attributed to the availability of a wide range of application-specific software that suits research requirements. Furthermore, biosimulation software is being used in clinical trials and it also eases modeling and target drug identification
  • By application, the drug development segment accounted for the largest share in 2020
  • Based on end use, pharmaceutical and biotechnology companies dominated the market in 2020 due to increasing strategic initiatives
  • North America grabbed the largest share in 2020. The presence of a favorable reimbursement framework (especially post the implementation of the Affordable Care Act) and sophisticated healthcare infrastructure is expected to drive the North American market over the forecast period
  • Asia Pacific is expected to grow significantly during the forecast period owing to the increase in the number of CROs, growth in spending on healthcare IT, and rapidly evolving healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biosimulation-market

Biosimulation Market Segmentation

Grand View Research has segmented the global biosimulation market on the basis of product, application, end use, and region:

Biosimulation Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Software
  • Services
    • In-house Services
    • Contract Services

Biosimulation Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Drug Development
  • Drug Discovery
  • Others

Biosimulation End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Regulatory Authorities
  • Academic Research Institutions

Biosimulation Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

List of Key Players of Biosimulation Market

  • Certara
  • DassaultSystemes
  • Advanced Chemistry Development
  • Simulation Plus
  • Schrodinger, Inc.
  • Chemical Computing Group ULC
  • PhysiomicsPlc
  • Rosa & Co. LLC
  • BioSimulation Consulting Inc.
  • Genedata AG
  • Instem Group of Companies
  • PPD, Inc. (Evidera)
  • Insilico Biotechnology AG
  • Immunetrics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In-vitro Toxicology Testing Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

 In-vitro Toxicology Testing Market Growth & Trends

The global in-vitro toxicology testing market size is expected to reach USD 51.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.7% from 2021 to 2028. In recent times, the validation and acceptance of in-vitro and alternative testing methods by regulatory agencies are increasing at lucrative pace. Also, ongoing technological advancements to replace the use of animals for toxicology testing purposes have spurred the use of in vitro testing models, in turn, driving the market.

Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.

With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity; absorption, distribution, metabolism, and excretion (ADME); pharmacovigilance; and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market. Several companies offer HTT-based in vitro toxicology analysis, e.g., Solidus Bioscience’s MetaChip Technology, which provides a solution for in vitro toxicology analysis using HTT.

Request a free sample copy or view report summary: In-vitro Toxicology Testing Market Report

In-vitro Toxicology Testing Market Report Highlights

  • Growing application of 3D-spheroid-cultures, particularly for nanoparticle toxicity testing, resulted in the dominance of the cell culture technology segment in 2020
  • Omics technology is anticipated to register lucrative growth over the forecast period as RNA sequencing and shotgun proteomics are increasingly used in research settings
  • The cosmetics industry is expected to be the fastest-growing segment in the near future, creating new avenues for the expansion of HTTs across the globe
  • The cellular assays segment dominated the market in 2020 owing to advancements in cell-based technologies, including label-free detection and high-content screening
  • The potential of cell imaging technologies is combined with high-content cell screening assays and high-throughput assays for the development of multi-parameter assays
  • Systemic toxicology emerged as the leading application segment in 2020 as it plays a key role in risk assessment during drug development procedures
  • For instance, toxicity testing of systemic immunosuppressive drugs and systemic corticosteroids is important during the development of drugs for ocular inflammatory disease
  • The pharmaceutical industry segment dominated the market in 2020 as toxicological testing is a prerequisite step for drug development
  • Stringent government regulations regarding animal usage for toxicity analysis in North America have led to an increased adoption rate of in-vitro models
  • In Asia Pacific, the market is anticipated to witness the fastest growth rate over the forecast period
  • This is due to increasing initiatives by public agencies to encourage acceptance of non-animal test models
  • The key participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silicoalgorithms for computational estimation of toxicity of pharmaceutical and chemical products
  • Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue

Access Press Release@ https://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-testing-market

In-vitro Toxicology Testing Market Segmentation

Grand View Research has segmented the global in-vitro toxicology testing market on the basis of end-use, technology, method, application, and region:

In-vitro Toxicology Testing End-use Outlook, (Revenue, USD Million, 2018 - 2028)

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes and Research Laboratories
  • Diagnostics
  • Chemical Industry
  • Food Industry

In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2018 - 2028)

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

In-vitro Toxicology Testing Application Outlook, (Revenue, USD Million, 2018 - 2028)

  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Others

In-vitro Toxicology Testing Method Outlook (Revenue, USD Million, 2018 - 2028)

  • Cellular Assay
    • Live Cells
      • High Throughput / High Content Screening
      • Molecular Imaging
        • Confocal Microscopy
        • Others
      • Others
    • Fixed Cells
  • Biochemical Assay
  • In-Silico
  • Ex-vivo

In-vitro Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • Middle East Africa (MEA)
    • South Africa

List of Key Players of In-vitro Toxicology Testing Market

  • Merck KGaA
  • Charles River
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • GE Healthcare
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Evotec
  • Creative Bioarray
  • Gentronix
  • BioIVT
  • SGS SA
  • Agilent Technologies.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...